QUALCOMM Incorporated

Isis Pharmaceuticals is a biopharmaceutical company that researches and develops therapeutic drugs for conditions, including inflammatory, metabolic, and cardiovascular diseases, and cancer. Founded in 1989, Isis owns more than 1,500 issued patents worldwide, and discovers and develops ribonucleic acid-based drugs. Its drug discovery and development division provides antisense inhibitors from its RNA-based technology. Its IBIS T5000 biosensor system is capable of identifying infectious organisms and is used by government agencies in biowarfare defense, epidemiological surveillance and forensics. The biosensor system is also used in pharmaceutical process control, hospital-associated infection control, and infectious disease diagnostics. Isis Pharmaceuticals is headquartered in Carlsbad, Calif.

Approximately 35 patents have been written and filed in regards to ethertronics isolated magnetic dipole, or IMD, technology. The company s key intellectual property is its proprietary IMD antenna technology. The IMD technology forms the underlying foundation for all the company s internal/embedded antenna products, which include mobile phone antennas, wireless local area network internal/embedded antennas and antenna modules. Located in San Diego, ethertronics serves high-volume wireless manufacturers by assisting them early in the product design cycle to optimize system performance, minimize antenna size, shorten time to market and reduce overall costs.